Severe supply chain disruptions for critical drugs are imminent due to increased COVID-19 cases and limited backfill of production from China. — Whalespan
Severe supply chain disruptions for critical drugs are imminent due to increased COVID-19 cases and limited backfill of production from China.
⚠ High risk
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
◐PARTIALLYSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“we are just beginning to feel the severe supply chain collision that's going to occur here in the next several weeks with increased number of cases of severe disease and these drugs that we need because in China the supply chains which were still thin were filled just before this outbreak started and there's about two to three months worth of supply in the chain but there was nothing that came in the back side of it so we're just about done”